News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
170,429 Results
Type
Article (31799)
Company Profile (11)
Press Release (138619)
Multimedia
Podcasts (4)
Webinars (9)
Section
Business (51904)
Career Advice (367)
Deals (3205)
Drug Delivery (7)
Drug Development (23802)
Employer Resources (32)
FDA (3305)
Job Trends (3163)
News (80205)
Policy (4143)
Tag
2024 Biotech Bay Standard (2)
2024 Pharm Country Standard (1)
2026 Biotech Bay Standard (1)
Academia (2399)
Academic (1)
Accelerated approval (2)
Adcomms (7)
Allergies (19)
Alliances (10808)
ALS (26)
Alzheimer's disease (518)
Antibody-drug conjugate (ADC) (17)
Approvals (3331)
Artificial intelligence (49)
Autoimmune disease (1)
Automation (3)
Bankruptcy (18)
Best Places to Work (2655)
BIOSECURE Act (3)
Biosimilars (8)
Biotechnology (13)
Bladder cancer (18)
Brain cancer (8)
Breast cancer (81)
Cancer (562)
Cardiovascular disease (38)
Career advice (339)
Career pathing (8)
CAR-T (41)
Cell therapy (110)
Cervical cancer (6)
Clinical research (18461)
Collaboration (154)
Compensation (8)
Complete response letters (1)
COVID-19 (1172)
CRISPR (12)
C-suite (139)
Cystic fibrosis (22)
Data (681)
Decentralized trials (1)
Denatured (3)
Depression (6)
Diabetes (51)
Diagnostics (1647)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (21)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (19)
Earnings (6243)
Editorial (3)
Employer branding (2)
Employer resources (29)
Events (17441)
Executive appointments (428)
FDA (3528)
Featured Employer (3)
Frontotemporal dementia (4)
Funding (188)
Gene editing (31)
Generative AI (3)
Gene therapy (72)
GLP-1 (125)
Government (938)
Guidances (3)
Healthcare (5027)
Huntington's disease (2)
IgA nephropathy (7)
Immunology and inflammation (10)
Indications (8)
Infectious disease (1205)
Inflammatory bowel disease (40)
Inflation Reduction Act (1)
Influenza (16)
Intellectual property (15)
Interviews (41)
IPO (1451)
IRA (6)
Job creations (573)
Job search strategy (318)
Kidney cancer (4)
Labor market (5)
Layoffs (32)
Leadership (2)
Legal (677)
Liver cancer (19)
Lung cancer (78)
Lymphoma (39)
Machine learning (1)
Management (9)
Manufacturing (38)
MASH (23)
Medical device (3020)
Medtech (3021)
Mergers & acquisitions (1798)
Metabolic disorders (113)
Multiple sclerosis (17)
NASH (5)
Neurodegenerative disease (23)
Neuropsychiatric disorders (1)
Neuroscience (632)
NextGen: Class of 2025 (1790)
Non-profit (1695)
Northern California (601)
Now hiring (3)
Obesity (39)
Opinion (28)
Ovarian cancer (30)
Pain (14)
Pancreatic cancer (26)
Parkinson's disease (34)
Partnered (3)
Patents (37)
Patient recruitment (30)
Peanut (12)
People (32209)
Phase I (5862)
Phase II (8459)
Phase III (5624)
Pipeline (176)
Policy (18)
Postmarket research (956)
Preclinical (3046)
Press Release (25)
Prostate cancer (26)
Psychedelics (8)
Radiopharmaceuticals (66)
Rare diseases (84)
Real estate (1271)
Recruiting (15)
Regulatory (2934)
Reports (3)
Research institute (1348)
Resumes & cover letters (23)
Rett syndrome (2)
RNA editing (1)
RSV (1)
Schizophrenia (8)
Series A (27)
Series B (18)
Sickle cell disease (16)
Southern California (470)
Spinal muscular atrophy (38)
Sponsored (6)
Startups (1101)
Stomach cancer (1)
Tariffs (1)
The Weekly (1)
United States (4577)
Vaccines (199)
Venture capitalists (1)
Weight loss (22)
Women's health (6)
Worklife (2)
Date
Today (11)
Last 7 days (114)
Last 30 days (568)
Last 365 days (7048)
2025 (1777)
2024 (7450)
2023 (9210)
2022 (11453)
2021 (13189)
2020 (12725)
2019 (12097)
2018 (8979)
2017 (8679)
2016 (8888)
2015 (10205)
2014 (7787)
2013 (7567)
2012 (7523)
2011 (7536)
2010 (6760)
Location
Africa (265)
Alabama (11)
Alaska (3)
Arizona (37)
Arkansas (6)
Asia (10357)
Australia (2606)
California (1253)
Canada (393)
China (92)
Colorado (56)
Connecticut (61)
Delaware (27)
Europe (27482)
Florida (155)
Georgia (47)
Idaho (12)
Illinois (117)
India (3)
Indiana (59)
Iowa (2)
Japan (43)
Kansas (13)
Kentucky (4)
Louisiana (1)
Maine (13)
Maryland (137)
Massachusetts (797)
Michigan (38)
Minnesota (64)
Mississippi (1)
Missouri (20)
Montana (6)
Nebraska (4)
Nevada (10)
New Hampshire (8)
New Jersey (356)
New Mexico (8)
New York (366)
North Carolina (256)
North Dakota (2)
Northern California (601)
Ohio (64)
Oklahoma (5)
Oregon (9)
Pennsylvania (248)
Puerto Rico (1)
Rhode Island (9)
South America (291)
South Carolina (3)
Southern California (470)
Tennessee (25)
Texas (183)
Utah (39)
Virginia (32)
Washington D.C. (17)
Washington State (133)
West Virginia (1)
Wisconsin (9)
170,429 Results for "mcgill university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QIAGEN collaborates with McGill University to advance microbiome research
November 13, 2024
·
8 min read
Biotech Bay
Bigfoot Biomedical Acquires Reinforcement Learning Algorithm for Insulin Titration Developed at McGill University
Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning algorithm for the titration of insulin settings developed at McGill University.
March 30, 2023
·
4 min read
Hemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre Foundation
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company”) is pleased to announce it has received a $250,000 Letter of Commitment for funding from the McGill University Health Centre (MUHC) Foundation.
January 19, 2023
·
8 min read
Business
InvestmentPitch Media Video Discusses Hemostemix and its $250,000 in Funding from McGill University Health Centre Foundation for Clinical Trial of ACP-01
Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF), an autologous stem cell therapy company, has received a $250,000 Letter of Commitment for funding from the McGill University Health Centre (MUHC) Foundation.
January 23, 2023
·
5 min read
Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
Alpha Tau Medical Ltd. announced today that its first patient with liver cancer metastases has been treated in a feasibility and safety study of Alpha DaRT at the McGill University Health Center in Montreal, Canada.
May 13, 2024
·
6 min read
Business
Fuzionaire to Collaborate with McGill University to Advance Chemistry Platform for Incorporation of Silicon into Pharmaceuticals
Fuzionaire, Inc. today announced a collaborative research agreement with McGill University that will leverage the company’s proprietary alkali metal catalyst platform in creating novel heterocyclic, biologically active, silicon-containing scaffolds and new silicon-based drug candidates.
September 1, 2022
·
3 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Business
Munich Re, Canada (Life) Announces Partnership with McGill University Health Centre (MUHC) Foundation to Advance Cutting-Edge Cardiovascular Disease Research
Munich Reinsurance Company’s Canadian life branch (Munich Re) is pleased to announce a partnership with the McGill University Health Centre (MUHC) Foundation to advance cutting-edge cardiovascular disease research.
December 2, 2021
·
3 min read
Drug Development
Promising COVID-19 Therapeutic Drug to start Phase 3 Clinical Trial in the United StatesPulmonem and the Research Institute of the McGill University Health Centre announce recruitment of first US-based patients
Pulmonem Inc. and the Research Institute of the McGill University Health Centre today announced that they have successfully started recruiting US-based patients for the Phase 3 Clinical Trial (ClinicalTrials.gov Identifier: NCT04935476) of the promising COVID-19 therapeutic drug PULM-001.
November 22, 2021
·
3 min read
1 of 17,043
Next
